COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020

Comparison of the COVID-19 vaccines developed by BioNTech/Pfizer and Moderna as of November 2020

You need to log in to download this statistic
Register for free
Already a member?
Log in
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

November 2020

Region

Worldwide

Survey time period

as of November 2020

Supplementary notes

* BioNTech/Pfizer: 1 severe case out of 8; Moderna: 0 severe case out of 5.
** BioNTech/Pfizer: 9 severe cases out of 162; Moderna: 11 severe cases out of 95.
*** Maximum estimate for Moderna.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.